drugset / Trial / NCT01314339

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

NCT01314339

Phase 1 Completed 28 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the rate and extent of absorption of Dr. Reddy's Desloratadine 5 mg tablet to that of Clarinex® 5 mg tablet in healthy subjects under fasting conditions.

Timeline

Start
2005-12
Primary completion
2005-12
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Desloratadine Small molecule 5 mg

Indications

No indication recorded.